CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-02-07): Common type of HCV successfully cultured in hepatoma cells

Science

Common type of HCV successfully cultured in hepatoma cells

Last Updated: 2006-02-07 10:40:25 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Using human hepatoma cells transfected with RNA from a prototype virus, researchers from the US and Japan have succeeded in culturing infectious genotype 1a hepatitis C virus (HCV).

Recently, a similar feat was accomplished for genotype 2a HCV, but that strain is less prevalent than the genotype 1a or "Hutchinson" strain and is not as closely linked to cirrhosis and liver cancer. In addition, the latter type is more likely to display interferon resistance.

Being able to grow infectious genotype 1a HCV in cell culture "will substantially benefit antiviral and vaccine discovery programs," senior author Dr. Stanley M. Lemon, from the University of Texas at Galveston, and colleagues note in the Proceedings of the National Academy of Sciences for February 14.

Proc Natl Acad Sci USA 2006;103:2310-2315.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.